Refika Dilara VAİZOĞLU, Harika Gözde GÖZÜKARA BAĞ, Ceren ACAR

The association between TLR4 polymorphisms and pulmonary tuberculosis

Tuberculosis (TB) is a major health problem which causes many deaths every year in the world. According to the World Health Organization (WHO) report, 1.5 million people lose their lives due to tuberculosis in every year. Although some of the infected people are showing the symptoms, in some the disease never develops, even about 90% of the affected ones are improved by the immune system's response. As in many infectious diseases, the difference between the number of infected people and the number of sick people is caused by differences in balance between the host defense and the virulence of the organism. In this case, the genetic basis of the response to infectious agents needs to be investigated in order to understand the relationship between infectious diseases and host. For this purpose; we investigated the effects of TLR4 polymorphisms (rs4986790 & rs4986791) that are involved in immune system mechanisms against susceptibility to Mycobacterium tuberculosis (MTB). In order to understand the association we did genotyping in 65 TB patients from Malatya. The results of the genotyping showed no significant association to the single nucleotide polymorphisms (SNPs) mentioned, for rs4986790 the p value was 0.80 and for rs4986791 p value was 0,517 for the genotypes. The population size was the limiting factor for the statistical analysis and it should be also taken into account that a number of genes are taking part in the signal transduction pathway that TLR4 is involved.

PDF

___

Global tuberculosis report 2017. Geneva: World Health Organization. 2017. Licence: CC BY-NCSA 3.0 IGO.

Ma X, Liu Y, Gowen BB, et al. Full-exon resequencing reveals tolllike receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One. 2007;2:1–9.

Vaizoglu RD. Investigation of some TLR polymorphisms in tuberculosis patients in Malatya. Master thesis, Inonu University, Malatya, 2017.

Botos I, Segal DM, Davies DR. Review the structural biology of toll-like receptors. Struct Des. 2011;19:447-59.

Thoma-Uszynski S, Ochoa MT, Engele M, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001; 291: 15-44.

Rock FL, Hardiman G, Timans JC, Kastelein R, Bazan J F. A family of human receptors structurally related to drosophila toll. PNAS. 1998;95:2 588-93.

Mcgettrick AF, O’Neill LA. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol Immunol. 2004;41:577-82.

Jahantigh D, Salimi S, Alavi-Naini R, et al. Association between TLR4 and TLR9 gene polymorphisms with development of pulmonary tuberculosis in Zahedan, southeastern Iran. ScientificWorld Journal. 2013;2013:534053.

Means TK, Wang S, Lien E, et al. Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis. J Immunol. 1999;3920-7.

Heldwein KA, Fenton, MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 2002;4:937-44.

Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 2010;8:4:296-307.

Thada S, Valluri VL, Gaddam SL. Influence of Toll-Like Receptor Gene Polymorphisms to Tuberculosis Susceptibility in Humans. Scand J Immunol. 2013;78:221-9.

Najmi N, Kaur G, Sharma SK, et al. Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens. 2010;76:102-9.

Turkey Tuberculosis War Report 2017. Ankara. Turkish Republic Ministry of Health; Ministry of Health Publication Number: 1091. 2017. ISBN: 978975-590-671-3.

Schurz H, Daya M, Möller M, et al. TLR1, 2, 4, 6 and 9 variants associated with tuberculosis susceptibility: A systematic review and meta-analysis. PLoS One. 2015;10:e0139711.

Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.

Nakada A, Hirasawa H, Oda S, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukin-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res. 2005;129:322-8.

Newport MJ, Allen A, Awomoyi AA, et al. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis. 2004;84:347-52.